Table 1.
Clinical profiles of patients from the Toronto Cohort. Values displayed as mean ± SD or median (IQR, interquartile range) as appropriate.
| Age (Years) | 33 (24–45) |
|---|---|
| Sex | n (%) |
| Female | 44 (86) |
| Male | 7 (14) |
| Creatinine (µmol/L) * | 68.5 (59.5–97.0) |
| Proteinuria (g/d) ** | 2.5 (1.5–5) |
| Mean Arterial Pressure (mm Hg) * | 98.8 ± 14.5 |
| Therapeutic Intervention | n (%) |
| Hydroxychloroquine | 30 (56) |
| RAAS Blocker | 22 (41) |
| Any Immunosuppression | 41 (76) |
| Prednisone alone | 16 (30) |
| Prednisone plus | |
| MMF | 11 (20) |
| AZT | 11 (20) |
| CNI † | 3 (6) |
| MTX † | 1 (2) |
Abbreviations: RAAS: Renal angiotensin aldosterone system. MMF: Mycophenolate mofetil/sodium, AZT: Azathioprine. CNI: Calcineurin inhibitor. MTX: Methotrexate. * Value closest to the time of biopsy; ** Value closest to time of biopsy; † One patient was receiving a combination of prednisone, CNI, and MTX. Another patient was receiving MTX monotherapy.